Tapewire

NYSE · USD

CVM

CEL SCI CORP

Export transactions ↓
Tapewire entity
7495
SEC CIK
0000725363
Parsed reports
298

Last 12 months

Inside the activity.

5 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202510
Jan 202610
Feb 202600
Mar 202600
Apr 202600
May 202620
Jun 202600
Jul 202600
Aug 202610
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
May 08, 2024 Filed May 9, 2024 13:19 UTC
KERSTEN GEERT RDirector · Chief Executive Officer
PurchaseCommon Stock 30,000 $1.39 $41,700.00
Disclosure

SEC source: 0001236030-24-000013 · primary_doc.xml · nonDerivative · entry 1

KERSTEN GEERT R · CIK 0001236030 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,195,309

F1 · shares: On May 8, 2024, Mr. Kersten purchased 30,000 shares of restricted stock directly from the Company at the closing price on May 8, 2024, the most recent closing price available.

Read SEC document
May 08, 2024 Filed May 10, 2024 13:04 UTC PurchaseCommon Stock 20,000 $1.39 $27,800.00
Disclosure

SEC source: 0001236030-24-000015 · primary_doc.xml · nonDerivative · entry 1

Watson Robert Eugene · CIK 0001511858 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,431

F1 · shares: On May 8, 2024, Mr. Watson purchased 20,000 shares of restricted stock directly from the Company at the closing price on May 8, 2024, the most recent closing price available.

Read SEC document
April 19, 2024 Filed Apr 23, 2024 21:20 UTC GrantOptions · Derivative 64,000 $0.01 Strike: $1.50 $640.00
Disclosure

SEC source: 0001236030-24-000010 · primary_doc.xml · derivative · entry 1

BAILLAVOINE BRUNO JEAN-MARIE · CIK 0001646989 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 725,500

Underlying: Common Stock · 64,000 shares

Expires 2034-04-18

F1 · derivative.exercise_date: The stock options vest in three (3) equal annual installments commencing one year after the grant date.

Read SEC document
April 19, 2024 Filed Apr 23, 2024 21:23 UTC GrantOptions · Derivative 64,000 $0.01 Strike: $1.50 $640.00
Disclosure

SEC source: 0001236030-24-000011 · primary_doc.xml · derivative · entry 1

Watson Robert Eugene · CIK 0001511858 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 698,000

Underlying: Common Stock · 64,000 shares

Expires 2034-04-18

F1 · derivative.exercise_date: The stock options vest in three (3) equal annual installments commencing one year after the grant date.

Read SEC document
April 19, 2024 Filed Apr 23, 2024 21:16 UTC
TALOR EYALChief Scientific Officer
GrantOptions · Derivative 182,000 $0.01 Strike: $1.50 $1,820.00
Disclosure

SEC source: 0001236030-24-000009 · primary_doc.xml · derivative · entry 1

TALOR EYAL · CIK 0001238028 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,998,646

Underlying: Common Stock · 182,000 shares

Expires 2034-04-18

F1 · derivative.exercise_date: The stock options vest in three (3) equal annual installments commencing one year after the grant date.

Read SEC document
April 19, 2024 Filed Apr 23, 2024 21:12 UTC
PRICHEP PATRICIA BSenior Vice President
GrantOptions · Derivative 167,000 $0.01 Strike: $1.50 $1,670.00
Disclosure

SEC source: 0001236030-24-000008 · primary_doc.xml · derivative · entry 1

PRICHEP PATRICIA B · CIK 0001236215 · Senior Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,893,797

Underlying: Common Stock · 167,000 shares

Expires 2034-04-18

F1 · derivative.exercise_date: The stock options vest in three (3) equal annual installments commencing one year after the grant date.

Read SEC document
April 19, 2024 Filed Apr 23, 2024 21:06 UTC
KERSTEN GEERT RDirector · Chief Executive Officer
GrantOptions · Derivative 250,000 $0.01 Strike: $1.50 $2,500.00
Disclosure

SEC source: 0001236030-24-000007 · primary_doc.xml · derivative · entry 1

KERSTEN GEERT R · CIK 0001236030 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,504,709

Underlying: Common Stock · 250,000 shares

Expires 2034-04-18

F1 · derivative.exercise_date: The stock options vest in three (3) equal annual installments commencing one year after the grant date.

Read SEC document
March 29, 2024 Filed Apr 2, 2024 13:13 UTC
TALOR EYALChief Scientific Officer
GrantCommon Stock 1,256 $1.91 $2,398.96
Disclosure

SEC source: 0001236030-24-000006 · primary_doc.xml · nonDerivative · entry 1

TALOR EYAL · CIK 0001238028 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 114,264

Read SEC document
March 29, 2024 Filed Apr 2, 2024 13:10 UTC
PRICHEP PATRICIA BSenior Vice President
GrantCommon Stock 2,246 $1.91 $4,289.86
Disclosure

SEC source: 0001236030-24-000005 · primary_doc.xml · nonDerivative · entry 1

PRICHEP PATRICIA B · CIK 0001236215 · Senior Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 224,326

Read SEC document
March 29, 2024 Filed Apr 2, 2024 13:08 UTC
KERSTEN GEERT RDirector · Chief Executive Officer
GrantCommon Stock 2,709 $1.91 $5,174.19
Disclosure

SEC source: 0001236030-24-000004 · primary_doc.xml · nonDerivative · entry 1

KERSTEN GEERT R · CIK 0001236030 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,165,309

Read SEC document
December 29, 2023 Filed Jan 2, 2024 14:06 UTC
TALOR EYALChief Scientific Officer
GrantCommon Stock 882 $2.72 $2,399.04
Disclosure

SEC source: 0001236030-24-000003 · primary_doc.xml · nonDerivative · entry 1

TALOR EYAL · CIK 0001238028 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 113,008

Read SEC document
December 29, 2023 Filed Jan 2, 2024 14:03 UTC
PRICHEP PATRICIA BSenior Vice President
GrantCommon Stock 1,577 $2.72 $4,289.44
Disclosure

SEC source: 0001236030-24-000002 · primary_doc.xml · nonDerivative · entry 1

PRICHEP PATRICIA B · CIK 0001236215 · Senior Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 222,080

Read SEC document
December 29, 2023 Filed Jan 2, 2024 14:00 UTC
KERSTEN GEERT RDirector · Chief Executive Officer
GrantCommon Stock 1,819 $2.72 $4,947.68
Disclosure

SEC source: 0001236030-24-000001 · primary_doc.xml · nonDerivative · entry 1

KERSTEN GEERT R · CIK 0001236030 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,162,600

Read SEC document
September 29, 2023 Filed Oct 3, 2023 14:43 UTC
TALOR EYALChief Scientific Officer
GrantCommon Stock 1,920 $1.25 $2,400.00
Disclosure

SEC source: 0001236030-23-000017 · primary_doc.xml · nonDerivative · entry 1

TALOR EYAL · CIK 0001238028 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 112,126

Read SEC document
September 29, 2023 Filed Oct 3, 2023 14:40 UTC
PRICHEP PATRICIA BSenior Vice President
GrantCommon Stock 3,432 $1.25 $4,290.00
Disclosure

SEC source: 0001236030-23-000016 · primary_doc.xml · nonDerivative · entry 1

PRICHEP PATRICIA B · CIK 0001236215 · Senior Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 220,503

Read SEC document
September 29, 2023 Filed Oct 3, 2023 14:37 UTC
KERSTEN GEERT RDirector · Chief Executive Officer
GrantCommon Stock 3,960 $1.25 $4,950.00
Disclosure

SEC source: 0001236030-23-000015 · primary_doc.xml · nonDerivative · entry 1

KERSTEN GEERT R · CIK 0001236030 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,160,781

Read SEC document
August 08, 2023 Filed Aug 10, 2023 20:53 UTC GrantOptions · Derivative 85,000 $0.01 Strike: $1.36 $850.00
Disclosure

SEC source: 0001236030-23-000014 · primary_doc.xml · derivative · entry 1

Naughton Gail K · CIK 0001297506 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 149,000

Underlying: Common Stock · 85,000 shares

Expires 2033-08-07

F1 · derivative.exercise_date: The stock options vest in three (3) equal annual installments commencing one year after the grant date.

Read SEC document
August 08, 2023 Filed Aug 10, 2023 20:50 UTC GrantOptions · Derivative 64,000 $0.01 Strike: $1.36 $640.00
Disclosure

SEC source: 0001236030-23-000013 · primary_doc.xml · derivative · entry 1

Watson Robert Eugene · CIK 0001511858 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 634,000

Underlying: Common Stock · 64,000 shares

Expires 2033-08-07

F1 · derivative.exercise_date: The stock options vest in three (3) equal annual installments commencing one year after the grant date.

Read SEC document
August 08, 2023 Filed Aug 10, 2023 20:46 UTC GrantOptions · Derivative 64,000 $0.01 Strike: $1.36 $640.00
Disclosure

SEC source: 0001236030-23-000012 · primary_doc.xml · derivative · entry 1

BAILLAVOINE BRUNO JEAN-MARIE · CIK 0001646989 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 661,500

Underlying: Common Stock · 64,000 shares

Expires 2033-08-07

F1 · derivative.exercise_date: The stock options vest in three (3) equal annual installments commencing one year after the grant date.

Read SEC document
August 08, 2023 Filed Aug 10, 2023 20:43 UTC GrantOptions · Derivative 64,000 $0.01 Strike: $1.36 $640.00
Disclosure

SEC source: 0001236030-23-000011 · primary_doc.xml · derivative · entry 1

YOUNG PETER R · CIK 0001238029 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 667,300

Underlying: Common Stock · 64,000 shares

Expires 2033-08-07

F1 · derivative.exercise_date: The stock options vest in three (3) equal annual installments commencing one year after the grant date.

Read SEC document
August 08, 2023 Filed Aug 10, 2023 20:40 UTC
CIPRIANO JOHNSenior Vice President
GrantOptions · Derivative 65,000 $0.01 Strike: $1.36 $650.00
Disclosure

SEC source: 0001236030-23-000010 · primary_doc.xml · derivative · entry 1

CIPRIANO JOHN · CIK 0001282304 · Senior Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 917,027

Underlying: Common Stock · 65,000 shares

Expires 2033-08-07

F1 · derivative.exercise_date: The stock options vest in three (3) equal annual installments commencing one year after the grant date.

Read SEC document
August 08, 2023 Filed Aug 10, 2023 20:37 UTC
TALOR EYALChief Scientific Officer
GrantOptions · Derivative 182,000 $0.01 Strike: $1.36 $1,820.00
Disclosure

SEC source: 0001236030-23-000009 · primary_doc.xml · derivative · entry 1

TALOR EYAL · CIK 0001238028 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,819,046

Underlying: Common Stock · 182,000 shares

Expires 2033-08-07

F1 · derivative.exercise_date: The stock options vest in three (3) equal annual installments commencing one year after the grant date.

Read SEC document
August 08, 2023 Filed Aug 10, 2023 20:32 UTC
PRICHEP PATRICIA BSenior Vice President
GrantOptions · Derivative 167,000 $0.01 Strike: $1.36 $1,670.00
Disclosure

SEC source: 0001236030-23-000008 · primary_doc.xml · derivative · entry 1

PRICHEP PATRICIA B · CIK 0001236215 · Senior Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,729,197

Underlying: Common Stock · 167,000 shares

Expires 2033-08-07

F1 · derivative.exercise_date: The stock options vest in three (3) equal annual installments commencing one year after the grant date.

Read SEC document
August 08, 2023 Filed Aug 10, 2023 20:28 UTC
KERSTEN GEERT RDirector · Chief Executive Officer
GrantOptions · Derivative 250,000 $0.01 Strike: $1.36 $2,500.00
Disclosure

SEC source: 0001236030-23-000007 · primary_doc.xml · derivative · entry 1

KERSTEN GEERT R · CIK 0001236030 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,258,309

Underlying: Common Stock · 250,000 shares

Expires 2033-08-07

F1 · derivative.exercise_date: The stock options vest in three (3) equal annual installments commencing one year after the grant date.

Read SEC document
June 30, 2023 Filed Jul 3, 2023 13:27 UTC
TALOR EYALChief Scientific Officer
GrantCommon Stock 995 $2.41 $2,397.95
Disclosure

SEC source: 0001236030-23-000006 · primary_doc.xml · nonDerivative · entry 1

TALOR EYAL · CIK 0001238028 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 110,206

Read SEC document
June 30, 2023 Filed Jul 3, 2023 13:24 UTC
PRICHEP PATRICIA BSenior Vice President
GrantCommon Stock 1,780 $2.41 $4,289.80
Disclosure

SEC source: 0001236030-23-000005 · primary_doc.xml · nonDerivative · entry 1

PRICHEP PATRICIA B · CIK 0001236215 · Senior Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 217,071

Read SEC document
June 30, 2023 Filed Jul 3, 2023 13:21 UTC
KERSTEN GEERT RDirector · Chief Executive Officer
GrantCommon Stock 2,053 $2.41 $4,947.73
Disclosure

SEC source: 0001236030-23-000004 · primary_doc.xml · nonDerivative · entry 1

KERSTEN GEERT R · CIK 0001236030 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,156,821

Read SEC document
March 31, 2023 Filed Apr 6, 2023 20:22 UTC
TALOR EYALChief Scientific Officer
GrantCommon Stock 1,034 $2.32 $2,398.88
Disclosure

SEC source: 0001236030-23-000003 · primary_doc.xml · nonDerivative · entry 1

TALOR EYAL · CIK 0001238028 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 109,211

Read SEC document
March 31, 2023 Filed Apr 6, 2023 20:19 UTC
PRICHEP PATRICIA BSenior Vice President
GrantCommon Stock 1,849 $2.32 $4,289.68
Disclosure

SEC source: 0001236030-23-000002 · primary_doc.xml · nonDerivative · entry 1

PRICHEP PATRICIA B · CIK 0001236215 · Senior Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 215,291

Read SEC document
March 31, 2023 Filed Apr 6, 2023 20:15 UTC
KERSTEN GEERT RDirector · Chief Executive Officer
GrantCommon Stock 2,133 $2.32 $4,948.56
Disclosure

SEC source: 0001236030-23-000001 · primary_doc.xml · nonDerivative · entry 1

KERSTEN GEERT R · CIK 0001236030 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,154,768

Read SEC document
December 30, 2022 Filed Jan 3, 2023 14:52 UTC
TALOR EYALChief Scientific Officer
GrantCommon Stock 1,021 $2.35 $2,399.35
Disclosure

SEC source: 0001236215-23-000003 · primary_doc.xml · nonDerivative · entry 1

TALOR EYAL · CIK 0001238028 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 108,177

Read SEC document
December 30, 2022 Filed Jan 3, 2023 14:49 UTC
PRICHEP PATRICIA BSenior Vice President
GrantCommon Stock 1,825 $2.35 $4,288.75
Disclosure

SEC source: 0001236215-23-000002 · primary_doc.xml · nonDerivative · entry 1

PRICHEP PATRICIA B · CIK 0001236215 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 213,442

Read SEC document
December 30, 2022 Filed Jan 3, 2023 14:46 UTC
KERSTEN GEERT RDirector · Chief Executive Officer
GrantCommon Stock 1,851 $2.35 $4,349.85
Disclosure

SEC source: 0001236215-23-000001 · primary_doc.xml · nonDerivative · entry 1

KERSTEN GEERT R · CIK 0001236030 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,152,635

Read SEC document
September 30, 2022 Filed Oct 3, 2022 11:23 UTC
ZIMMERMAN DANIEL HSenior Vice President
GrantCommon Stock 1,266 $3.09 $3,911.94
Disclosure

SEC source: 0001236215-22-000008 · primary_doc.xml · nonDerivative · entry 1

ZIMMERMAN DANIEL H · CIK 0001236028 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 120,226

Read SEC document
September 30, 2022 Filed Oct 3, 2022 11:21 UTC
TALOR EYALChief Scientific Officer
GrantCommon Stock 776 $3.09 $2,397.84
Disclosure

SEC source: 0001236215-22-000007 · primary_doc.xml · nonDerivative · entry 1

TALOR EYAL · CIK 0001238028 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 107,156

Read SEC document
September 30, 2022 Filed Oct 3, 2022 11:15 UTC
KERSTEN GEERT RDirector · Chief Executive Officer
GrantCommon Stock 1,407 $3.09 $4,347.63
Disclosure

SEC source: 0001236215-22-000005 · primary_doc.xml · nonDerivative · entry 1

KERSTEN GEERT R · CIK 0001236030 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,150,784

Read SEC document
September 30, 2022 Filed Oct 3, 2022 11:18 UTC
PRICHEP PATRICIA BSenior Vice President
GrantCommon Stock 1,388 $3.09 $4,288.92
Disclosure

SEC source: 0001236215-22-000006 · primary_doc.xml · nonDerivative · entry 1

PRICHEP PATRICIA B · CIK 0001236215 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 211,617

Read SEC document
June 30, 2022 Filed Jul 5, 2022 13:22 UTC
ZIMMERMAN DANIEL HSenior Vice President
GrantCommon Stock 876 $4.50 $3,942.00
Disclosure

SEC source: 0001236215-22-000004 · primary_doc.xml · nonDerivative · entry 1

ZIMMERMAN DANIEL H · CIK 0001236028 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 118,960

Read SEC document
June 30, 2022 Filed Jul 5, 2022 13:20 UTC
TALOR EYALChief Scientific Officer
GrantCommon Stock 533 $4.50 $2,398.50
Disclosure

SEC source: 0001236215-22-000003 · primary_doc.xml · nonDerivative · entry 1

TALOR EYAL · CIK 0001238028 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 106,380

Read SEC document
June 30, 2022 Filed Jul 5, 2022 13:17 UTC
PRICHEP PATRICIA BSenior Vice President
GrantCommon Stock 953 $4.50 $4,288.50
Disclosure

SEC source: 0001236215-22-000002 · primary_doc.xml · nonDerivative · entry 1

PRICHEP PATRICIA B · CIK 0001236215 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 210,229

Read SEC document
June 30, 2022 Filed Jul 5, 2022 13:14 UTC
KERSTEN GEERT RDirector · Chief Executive Officer
GrantCommon Stock 966 $4.50 $4,347.00
Disclosure

SEC source: 0001236215-22-000001 · primary_doc.xml · nonDerivative · entry 1

KERSTEN GEERT R · CIK 0001236030 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,149,377

Read SEC document
June 13, 2022 Filed Jun 14, 2022 21:30 UTC GrantOptions · Derivative 64,000 $0.01 Strike: $3.35 $640.00
Disclosure

SEC source: 0001236030-22-000016 · primary_doc.xml · derivative · entry 1

Watson Robert Eugene · CIK 0001511858 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 570,000

Underlying: Common Stock · 64,000 shares

Expires 2032-06-12

F1 · derivative.exercise_date: The stock options vest in three (3) equal annual installments commencing one year after the grant date.

Read SEC document
June 13, 2022 Filed Jun 14, 2022 21:28 UTC GrantOptions · Derivative 64,000 $0.01 Strike: $3.35 $640.00
Disclosure

SEC source: 0001236030-22-000015 · primary_doc.xml · derivative · entry 1

BAILLAVOINE BRUNO JEAN-MARIE · CIK 0001646989 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 597,500

Underlying: Common Stock · 64,000 shares

Expires 2032-06-12

F1 · derivative.exercise_date: The stock options vest in three (3) equal annual installments commencing one year after the grant date.

Read SEC document
June 13, 2022 Filed Jun 14, 2022 21:26 UTC GrantOptions · Derivative 64,000 $0.01 Strike: $3.35 $640.00
Disclosure

SEC source: 0001236030-22-000014 · primary_doc.xml · derivative · entry 1

YOUNG PETER R · CIK 0001238029 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 606,200

Underlying: Common Stock · 64,000 shares

Expires 2032-06-12

F1 · derivative.exercise_date: The stock options vest in three (3) equal annual installments commencing one year after the grant date.

Read SEC document
June 13, 2022 Filed Jun 14, 2022 21:24 UTC
ZIMMERMAN DANIEL HSenior Vice President
GrantOptions · Derivative 80,000 $0.01 Strike: $3.35 $800.00
Disclosure

SEC source: 0001236030-22-000013 · primary_doc.xml · derivative · entry 1

ZIMMERMAN DANIEL H · CIK 0001236028 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 832,353

Underlying: Common Stock · 80,000 shares

Expires 2032-06-12

F1 · derivative.exercise_date: The stock options vest in three (3) equal annual installments commencing one year after the grant date.

Read SEC document
June 13, 2022 Filed Jun 14, 2022 21:21 UTC
CIPRIANO JOHNSenior Vice President
GrantOptions · Derivative 65,000 $0.01 Strike: $3.35 $650.00
Disclosure

SEC source: 0001236030-22-000012 · primary_doc.xml · derivative · entry 1

CIPRIANO JOHN · CIK 0001282304 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 852,927

Underlying: Common Stock · 65,000 shares

Expires 2032-06-12

F1 · derivative.exercise_date: The stock options vest in three (3) equal annual installments commencing one year after the grant date.

Read SEC document
June 13, 2022 Filed Jun 14, 2022 21:19 UTC
TALOR EYALChief Scientific Officer
GrantOptions · Derivative 182,000 $0.01 Strike: $3.35 $1,820.00
Disclosure

SEC source: 0001236030-22-000011 · primary_doc.xml · derivative · entry 1

TALOR EYAL · CIK 0001238028 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,644,246

Underlying: Common Stock · 182,000 shares

Expires 2032-06-12

F1 · derivative.exercise_date: The stock options vest in three (3) equal annual installments commencing one year after the grant date.

Read SEC document
June 13, 2022 Filed Jun 14, 2022 21:16 UTC
PRICHEP PATRICIA BSenior Vice President
GrantOptions · Derivative 167,000 $0.01 Strike: $3.35 $1,670.00
Disclosure

SEC source: 0001236030-22-000010 · primary_doc.xml · derivative · entry 1

PRICHEP PATRICIA B · CIK 0001236215 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,569,397

Underlying: Common Stock · 167,000 shares

Expires 2032-06-12

F1 · derivative.exercise_date: The stock options vest in three (3) equal annual installments commencing one year after the grant date.

Read SEC document
June 13, 2022 Filed Jun 14, 2022 21:13 UTC
KERSTEN GEERT RDirector · Chief Executive Officer
GrantOptions · Derivative 250,000 $0.01 Strike: $3.35 $2,500.00
Disclosure

SEC source: 0001236030-22-000009 · primary_doc.xml · derivative · entry 1

KERSTEN GEERT R · CIK 0001236030 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,030,109

Underlying: Common Stock · 250,000 shares

Expires 2032-06-12

F1 · derivative.exercise_date: The stock options vest in three (3) equal annual installments commencing one year after the grant date.

Read SEC document
March 31, 2022 Filed Mar 31, 2022 20:56 UTC
ZIMMERMAN DANIEL HSenior Vice President
GrantCommon Stock 1,006 $3.93 $3,953.58
Disclosure

SEC source: 0001236030-22-000008 · primary_doc.xml · nonDerivative · entry 1

ZIMMERMAN DANIEL H · CIK 0001236028 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 118,084

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.